More Antipsychotic Drugs Get Stronger Warning Labels

The US Food and Drug Administration (FDA) announced today that some “conventional” antipsychotic prescription drugs must now carry a black box warning label just like the one that has come on newer antipsychotic drug labels since an FDA order in 2005. The black box message is that the drugs increase the risk of death for elderly patients suffering from dementia. Read more

Common Schizophrenia Drug on Trial

The pharmaceutical giant, Eli Lilly, is being sued by the state of Alaska over allegedly covering up the potential risks of Zyprexa (olanzapine). Attorneys for the state argue that the company knew that the drug, approved for the treatment of Schizophrenia and acute manic and mixed episodes of Bipolar Disorder, may cause diabetes in patients taking it. Read more